We read with interest the results and conclusions based on the chart review of patients receiving long-term steroid treatment by Drs Edin and Arsad Karcic. In our cohort of 229 long-term corticosteroid users,1 only 18% (41/229) were receiving some form of osteoporosis prevention (hormone replacement, bisphosphonate, or vitamin D analogue). Only 4% (3/72) of the men were receiving osteoporosis prevention, compared with 24% (38/157) of the women. On further analysis, we found that, apart from sex, none of the other variables, such as age, current steroid use, duration of steroid use, bone density, or presence of vertebral deformity, was predictive of whether treatment for osteoporosis prevention had been initiated. The ad hoc basis on which treatment for osteoporosis prevention was initiated in our study group is in contrast to the clear recommendation outlined in recent guidelines. A guideline directed at patients using 7.5 mg/d or more of prednisone (equivalent) that was developed in the United Kingdom recommends treatment for patients who have one or more of the following criteria: presence of osteoporotic fractures, age older than 65 years (irrespective of sex), strong risk factors for osteoporosis, and low bone density.2 The results of our study also provide an insight into what might be happening in everyday clinical practice. In a survey of Australian rheumatologists, more than 80% said they would initiate treatment (hormone replacement, bisphosphonate, or vitamin D analogue) to prevent osteoporosis in postmenopausal women who are starting corticosteroid therapy.3 In practice, however, this figure seems to be much lower.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
Users' Guides to the Medical Literature
A trial of sodium fluoride as secondary prevention against osteoporosis in postmenopausal women...
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.